Immunocore Holdings PLC
NASDAQ:IMCR

Watchlist Manager
Immunocore Holdings PLC Logo
Immunocore Holdings PLC
NASDAQ:IMCR
Watchlist
Price: 32.28 USD 0.5% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Immunocore Holdings PLC?
Write Note

Relative Value

The Relative Value of one IMCR stock under the Base Case scenario is 118.25 USD. Compared to the current market price of 32.28 USD, Immunocore Holdings PLC is Undervalued by 73%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMCR Relative Value
Base Case
118.25 USD
Undervaluation 73%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
91
vs Industry
71
Median 3Y
14.1
Median 5Y
16.4
Industry
7.7
Forward
4
vs History
vs Industry
Median 3Y
-25.9
Median 5Y
-21.7
Industry
22.7
Forward
-21.4
vs History
31
vs Industry
0
Median 3Y
-9.6
Median 5Y
-12.4
Industry
21.6
vs History
31
vs Industry
11
Median 3Y
-8.8
Median 5Y
-11.9
Industry
25.2
vs History
91
vs Industry
22
Median 3Y
7.2
Median 5Y
7
Industry
2.5
vs History
91
vs Industry
65
Median 3Y
12.5
Median 5Y
14.6
Industry
7.7
Forward
2.7
vs History
63
vs Industry
67
Median 3Y
9.2
Median 5Y
7.8
Industry
9
vs History
vs Industry
Median 3Y
-21.2
Median 5Y
-18.8
Industry
4.2
Forward
-11.2
vs History
vs Industry
Median 3Y
-20.4
Median 5Y
-16.1
Industry
4.1
Forward
-9.9
vs History
31
vs Industry
0
Median 3Y
-7.8
Median 5Y
-10.5
Industry
5.7
vs History
25
vs Industry
1
Median 3Y
-10.4
Median 5Y
-11.8
Industry
3.6
vs History
91
vs Industry
25
Median 3Y
16.8
Median 5Y
17.2
Industry
4.6

Multiples Across Competitors

IMCR Competitors Multiples
Immunocore Holdings PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Immunocore Holdings PLC
NASDAQ:IMCR
1.6B USD 2.8 -14.5 -8.7 -8.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 38 083 264.3 -181 004.1 -219 796.6 -217 288.5
US
Abbvie Inc
NYSE:ABBV
312.7B USD 5.6 61.5 15.3 23.6
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
116.2B USD 10.9 -242.3 24.1 25.3
US
Gilead Sciences Inc
NASDAQ:GILD
112.4B USD 4 891.9 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 849.9 -472 -514.1 -500.3
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
81.3B USD 5.9 17.5 15.9 17.7
US
Seagen Inc
F:SGT
39.3B EUR 17.8 -54.6 -58.7 -53
NL
argenx SE
XBRU:ARGX
34.8B EUR 18.7 -131 -105.5 -76.9
P/E Multiple
Earnings Growth
UK
Immunocore Holdings PLC
NASDAQ:IMCR
Average P/E: 208.2
Negative Multiple: -14.5
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -181 004.1 N/A
US
Abbvie Inc
NYSE:ABBV
61.5
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -242.3
42%
US
Gilead Sciences Inc
NASDAQ:GILD
891.9
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -472 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.6 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -131 N/A
EV/EBITDA Multiple
EBITDA Growth
UK
Immunocore Holdings PLC
NASDAQ:IMCR
Average EV/EBITDA: 17.2
Negative Multiple: -8.7
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -219 796.6 N/A
US
Abbvie Inc
NYSE:ABBV
15.3
29%
US
Amgen Inc
NASDAQ:AMGN
17.5
62%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.1
43%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
16%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -514.1 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
15.9
35%
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.5 N/A
EV/EBIT Multiple
EBIT Growth
UK
Immunocore Holdings PLC
NASDAQ:IMCR
Average EV/EBIT: 22.5
Negative Multiple: -8.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -217 288.5 N/A
US
Abbvie Inc
NYSE:ABBV
23.6
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.3
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -500.3 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.9 N/A

See Also

Discover More
Back to Top